CD38 and non-Hodgkin lymphoma: CD38 is abundantly expressed in multiple myeloma (MM) (26) and some non-Hodgkin’s lymphomas (NHLs) (27, 30, 33, 34), and is emerging as a new therapeutic target for these diseases.